Sponsor
Foundation for Innovative New Diagnostics, Switzerland
Clinical research sponsor
Clinical trials
10 shownEvaluating Next Generation LAM Assays and Molecular Diagnostics (POC and Near POC) for the Diagnosis of TB Among People With Presumptive TB: a Prospective Multicentre Diagnostic Accuracy StudyNCT06019052 · lead sponsor · 2025-09-01
NOT_YET_RECRUITINGUse of Continuous Glucose Monitoring Devices Among People Living With Type 1 Diabetes in South AfricaNCT05944718 · lead sponsor · 2023-09-11
COMPLETEDUse of Continuous Glucose Monitoring Devices Among People Living With Type 1 Diabetes in Kenya.NCT05944731 · lead sponsor · 2023-09-03
SUSPENDEDBGM and HbA1c POC Device EvaluationNCT06170515 · lead sponsor · 2023-06-09
COMPLETEDTB-CAPT EXULTANT - HIVNCT04568967 · lead sponsor · 2022-09-05
COMPLETEDCardiometabolic Devices Accuracy StudyNCT05257564 · lead sponsor · 2022-02-14
COMPLETEDFujiLAM Prospective Evaluation TrialNCT04089423 · lead sponsor · 2019-12-13
COMPLETEDEvaluation Study of RDTs Detecting Antibodies Against HCVNCT04033887 · lead sponsor · 2018-09-21
COMPLETEDEvaluating the Impact of Computer-assisted X-ray Diagnosis and Other Triage Tools to Optimise Xpert Orientated Community-based Active Case Finding for TB and COVID-19NCT05220163 · collaborator · 2022-02-23
ACTIVE_NOT_RECRUITINGDiagnostic Accuracy of CAD4TB and C-reactive Protein Assay as Triage Tests for Pulmonary TuberculosisNCT04666311 · collaborator · 2021-02-15
COMPLETEDSponsor roles
lead sponsor8
collaborator2
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.